Metropolitan Life Insurance Company (MetLife)’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,299
Closed -$61K 71
2024
Q1
$61K Sell
5,299
-284
-5% -$2.41K ﹤0.01% 1306
2023
Q4
$40.7K Hold
5,583
﹤0.01% 1554
2023
Q3
$50.8K Buy
5,583
+1,478
+36% +$17.7K ﹤0.01% 1390
2023
Q2
$50K Hold
4,105
﹤0.01% 1412
2023
Q1
$51K Sell
4,105
-352
-8% -$6.48K ﹤0.01% 1380
2022
Q4
$85.7K Hold
4,457
﹤0.01% 1139
2022
Q3
$83.7K Hold
4,457
﹤0.01% 1124
2022
Q2
$80.4K Hold
4,457
﹤0.01% 1196
2022
Q1
$71.4K Sell
4,457
-15,033
-77% -$270K ﹤0.01% 1390
2021
Q4
$477K Hold
19,490
0.01% 1469
2021
Q3
$454K Sell
19,490
-2,224
-10% -$53.8K 0.01% 1527
2021
Q2
$595K Buy
21,714
+1,024
+5% +$29.2K 0.01% 1406
2021
Q1
$761K Buy
20,690
+12,963
+168% +$458K 0.01% 1141
2020
Q4
$290K Hold
7,727
﹤0.01% 1693
2020
Q3
$169K Buy
+7,727
New +$162K ﹤0.01% 1883

Other funds holding AHCO

Metropolitan Life Insurance Company (MetLife)'s AHCO Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of AdaptHealth (AHCO) in Q2 2024, closing a stake of 5,299 shares — an estimated $61K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AHCO in Q3 2020 and held it in 15 quarters. The position peaked at $761K in Q1 2021. 207 funds tracked by Wall St. Rank hold AHCO as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining AdaptHealth position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 5,299 AdaptHealth shares in Q2 2024, an estimated $61K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in AdaptHealth in Q3 2020 and held it in 15 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s AdaptHealth position peaked at $761K in Q1 2021.
  • 207 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.